JENNIFER LYN JEFFRIES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LUDINGTON, MI NPI 1962992958
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MI Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,439.46
- Category: General Payments
- Program years: PY2023–2024
- Record count: 53
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,297.44 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,224.71 | 46 |
| Education | $72.73 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $185.68 | 4 |
| Janssen Biotech, Inc. | $165.17 | 4 |
| Gilead Sciences, Inc. | $125.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $120.53 | 5 |
| PFIZER INC. | $79.54 | 6 |
| SEAGEN INC. | $72.73 | 1 |
| Daiichi Sankyo Inc. | $71.88 | 3 |
| EISAI INC. | $53.18 | 2 |
| Apellis Pharmaceuticals, Inc. | $52.61 | 3 |
| Merck Sharp & Dohme Corporation | $46.24 | 2 |
| Celgene Corporation | $45.12 | 3 |
| Astellas Pharma US Inc | $43.98 | 2 |
| Genentech USA, Inc. | $36.78 | 2 |
| Tempus AI, Inc | $28.71 | 1 |
| E.R. Squibb & Sons, L.L.C. | $28.06 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.93 | 1 |
| Agios Pharmaceuticals, Inc. | $22.55 | 1 |
| Kite Pharma, Inc. | $21.15 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $20.84 | 1 |
| Incyte Corporation | $18.39 | 1 |
| Sumitomo Pharma America, Inc. | $16.72 | 1 |
| Mirati Therapeutics, Inc. | $15.65 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.